Coverage
-
March 12, 2014
A Virginia federal judge on Wednesday invalidated a key Pfizer Inc. reissue patent covering methods for administering its blockbuster arthritis drug Celebrex, a ruling exposing the company to competition from generics makers.
1 other articles on this case.
View all »